Study reveals structural insights into the elusive tankyrase protein that fuels bowel cancer
Can't see this email? View it online
   
  Oncology  
  The latest oncology news from News Medical  
 Common chemotherapy drug could carry toxic inheritance for future generations of cancer survivorsCommon chemotherapy drug could carry toxic inheritance for future generations of cancer survivors
 
A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington State University-led research indicates.
 
 
 Study reveals structural insights into the elusive tankyrase protein that fuels bowel cancerStudy reveals structural insights into the elusive tankyrase protein that fuels bowel cancer
 
Scientists have revealed the inner workings of a key protein involved in a wide range of cellular processes – potentially paving the way for better and less toxic cancer drugs.
 
   High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of lifeHigh-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life
 
Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.
 
   Novel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapyNovel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapy
 
University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study published today.
 
   Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UKGovernment introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK
 
NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.
 
 Scientists move a step closer to advancing personalized cancer treatment
 
Scientists move a step closer to advancing personalized cancer treatmentIn a step likely to advance personalized cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.
 
 
 New research could be the first step in better targeting breast cancer treatment
 
New research could be the first step in better targeting breast cancer treatmentResearchers have identified a protein that, when present in high amounts in breast cancer tumors, is an indicator of whether DNA-damaging therapies will work or not.
 
 
 CAR T therapy extends its reach beyond oncology
 
CAR T therapy extends its reach beyond oncologyEngineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers.
 
 
 Simultaneous radiation and immunotherapy can benefit mNSCLC patients with high tumor aneuploidy
 
Simultaneous radiation and immunotherapy can benefit mNSCLC patients with high tumor aneuploidyIn many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells.
 
 
 Unexplored NGS data could help elucidate carcinogenesis and discover biomarkers
 
Unexplored NGS data could help elucidate carcinogenesis and discover biomarkersA new research perspective was published in Oncotarget's Volume 13 on November 17, 2022, entitled, "Treasures from trash in cancer research."
 
 
 Researchers highlight the importance of localizing BRCA gene mutations for better ovarian cancer treatment
 
Researchers highlight the importance of localizing BRCA gene mutations for better ovarian cancer treatmentMutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1 in 800 people respectively, significantly increase the risk of certain cancers such as ovarian, breast, pancreatic and prostate cancer.
 
 
 Breakthrough on the way to new therapeutic strategies
 
Breakthrough on the way to new therapeutic strategiesAs far as the field of cancer research is concerned, hollow spheres composed of MYC proteins sets the stage. Researchers from Würzburg have found them out and have reported this discovery in the Nature journal.
 
 
 Tankyrase protein plays an important role in helping drive bowel cancer
 
Tankyrase protein plays an important role in helping drive bowel cancerThe inner workings of the main protein involved in an extensive range of cellular processes have been disclosed by researchers. This possibly sets the stage for improved and less toxic cancer drugs.